Related Experiment Video
Updated: Apr 21, 2026
04:03
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
1.7K
Triple combinations in chronic obstructive pulmonary disease - is three better than two?
Mario Cazzola1, Maria Gabriella Matera
1University of Rome Tor Vergata, Department of Systems Medicine, Unit of Respiratory Clinical Pharmacology , Via Montpellier 1, Rome 00133 , Italy mario.cazzola@uniroma2.it.
Expert Opinion on Pharmacotherapy
|October 21, 2014
Summary
Triple therapy, combining three medications, shows promise for managing chronic obstructive pulmonary disease (COPD). Further research is needed to establish strong recommendations for its optimal use in COPD patients.
Area of Science:
- Pulmonology
- Pharmacology
Background:
- Triple therapy (antimuscarinic, long-acting β2-agonist, inhaled corticosteroid) is increasingly recognized for its efficacy in severe chronic obstructive pulmonary disease (COPD), particularly in patients experiencing frequent exacerbations.
- This combination therapy is frequently implemented in real-world COPD management, extending beyond patients with severe disease.
Discussion:
- The attractiveness of triple therapy stems from its demonstrated efficacy and widespread clinical application.
- Ongoing development of various triple therapy combinations highlights its therapeutic potential.
Key Insights:
- Evidence supports the efficacy of triple therapy in severe COPD with frequent exacerbations.
- Real-world use of triple therapy in COPD is common, even in less severe cases.
Outlook:
- Further research is essential to address current limitations, including scarce data and short study durations.
- Optimization of triple therapy use in COPD requires more robust evidence to support strong clinical recommendations.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.1K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.1K
01:24Chronic Obstructive Pulmonary Disease
3.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
21
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
21